Plasma CCL5 concentrations are significantly elevated in SLE patients when compared with normal controls and correlate with autoantibody levels, indicating that this chemokine might be involved in SLE pathogenesis [75]. The gene discussed is CCL5; the disease is systemic lupus erythematosus.